#85 - Telemedicine Under Watch: The Summer That Changed the Rules

 It was the summer telemedicine stopped getting a pass. In this episode of Telemedicine Talks, Phoebe Gutierrez and Dr. Leo Damasco recap major telemedicine developments from the summer, focusing on increasing regulatory and enforcement activity. They discuss the DEA’s progress toward final controlled-substance prescribing rules and what greater federal oversight could mean for telemedicine companies operating in this rapidly evolving space. They both examine FTC action against Hims & Hers, including subscription practices and cancellation requirements, while questioning whether traditional healthcare regulations adequately fit cash-pay telemedicine. They also discuss Eli Lilly’s lawsuits involving Retatrutide, emphasizing the potential risks physicians face when prescribing non-FDA-approved treatments and the growing attention from state medical boards. Finally, they explore corporate practice of medicine enforcement, including Carbon Health’s settlement and evolving PC/MSO requirements, before turning to the growth of white-label telemedicine companies. The episode highlights why physicians must understand their responsibilities, review their agreements, stay informed about regulations, build specialized expertise, and find ways to distinguish themselves in an increasingly competitive telemedicine market. Three Actionable Takeaways: Regulatory scrutiny is increasing: From controlled-substance prescribing to FTC enforcement and corporate practice of medicine, telemedicine companies should expect more oversight and be prepared to adapt as regulators catch up with the industry. Physicians remain responsible for their clinical decisions: Technology, workflows, businesses, and platforms may support physicians, but ultimately the physician must understand what they are prescribing and ensure they are practicing appropriately and within applicable rules. The telemedicine market is becoming more competitive: The growth of white-label companies and the increasing number of physicians entering telehealth means physicians need to develop relationships, specialized expertise, and other distinguishing skills to stand out. About the Show: Telemedicine Talks explores the evolving world of digital health, helping physicians navigate new opportunities, regulatory challenges, and career transitions in telemedicine. About the Hosts: Dr. Leo Damasco – Pediatrician and emergency medicine doctor turned telemedicine advocate, helping physicians transition to digital health. Phoebe Gutierrez – Former state regulator turned telehealth executive, specializing in compliance and sustainable virtual care models. Connect with Phoebe Gutierrez:https://www.linkedIn.com/in/pkgutierrez/  [email protected] (mailto:[email protected]) The information provided in Telemedicine Talks is for educational and informational purposes only and should not be construed as medical, legal, or financial advice. While we discuss best practices, industry trends, and real-world experiences, every situation is unique. Listeners should consult with qualified professionals before making decisions related to telemedicine practice, compliance, contracts, or business operations. The views expressed by the hosts and guests are their own and do not necessarily reflect those of any organizations they may be affiliated with. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.